Food Bits and Bytes Go Exclusively Online with Launch of Eat In Eat Out Magazine
Toronto, Canada (PRWEB) November 15, 2011
Canada’s first food-focused digital magazine – Eat In Eat Out Magazine (EIEO) is your one stop (gourmet) shop for delicious news and recipes that are fit to print. From chef and home-economist tested seasonal recipes to trustworthy restaurant reviews and chef interviews, EIEO is for anyone craving reliable, engaging content and who loves to cook at home or dine out.
Created and conceived by Lori Kennedy – the President of Avalon Custom Content, a custom content provider to the food industry spanning almost two decades, Eat In Eat Out Magazine reflects Kennedy’s love of cooking and dining. “You can never have too many recipes. Our recipes are approachable, simple and great tasting. Our content is not just for ‘super-foodies.’ Time-saving use of packaged goods as ingredients is not off-limits. It’s for real every-day cooks,” says Kennedy.
The inaugural, Holiday Entertaining issue will feature content (and a recipe) from Canadian celebrity chef Christine Cushing as well as a witty sign-off column from food personality, Denise Vivaldo. Kennedy has partnered with a network of home economists, recipe developers, food writers and top Canadian food bloggers to provide a unique voice in the digital food sphere. Amongst these, you’ll find Canadian food and wine writer Shari Darling, author of “Orgasmic Appetizers and Matching Wines,” who will be sharing some of her recipes in the Holiday issue.
The beauty of EIEO is that it is a truly digital creation with all of the benefits that follow; Kennedy has recreated the comfortable editorial format found in most print magazines while adding the interactive and engaging experience of embedded links, audio, videos, recipe searchability, archived back issues and contests.
With ‘Eat In’ covering off cozy nights spent at home, the ‘Eat out’ half of the magazine covers the scene beyond your doorstep by tapping into the regional expertise of food writers for restaurant reviews and chef features from across Canada. “We have created a simple 12-step ‘at a glance’ restaurant review that gets to the point quickly. What is the vibe, can I bring my kids, what kind of food, and how much?” says Kennedy.
“I feel very strongly that EIEO brings together marketers, food bloggers and consumers in a unique way. I am excited about exploring this new distribution method,” says Kennedy, adding, “Up until now, the printed vehicles we produce are mailed out and we rarely get any feedback from consumers. As an online publication, social media will play a key role in spreading the word, building a following, and creating a community of readers, bloggers and marketers that will be immediate and interactive. That’s very exciting.”
EIEO will be published quarterly with fresh, tasty content added regularly to whet your appetite for food news that will have you coming back for seconds.
# # #
©Copyright 1997-, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
©Copyright 1997-, Vocus PRW Holdings, LLC.
– by
Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia

xml:lang=”en” lang=”en” xmlns=”http://www.w3.org/1999/xhtml”>
Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia
Feinstein Institute/North Shore LIJ Logo
Manhasset, NY (Vocus) July 22, 2009
People with schizophrenia have long received an inconsistent mix of treatments depending on where they lived and what doctors they saw. Now, the federal government has announced an innovative study to test the impact of the best available treatments and whether the interventions will reduce future episodes of schizophrenia and help young people get their brains and lives back on track.
The study, called RAISE, is a contract funded by the National Institute of Mental Health, the National Institutes of Health and the American Recovery and Reinvestment Act (ARRA). The government will fund $ 40 million over six years — of which about half is earmarked for scientists at The Zucker Hillside Hospital campus of The Feinstein Institute for Medical Research. The project will involve two independent teams of researchers, one being led by Zucker Hillside/Feinstein scientists and another at Columbia Universityâs New York State Psychiatric Institute.
The interventions include the latest pharmacological and psychosocial treatments; the study design includes doctors, patients, families and scientists who will weigh in on the interventions to identify what works and what doesnât. Once the intervention package is complete, scientists will train doctors and other health professionals throughout the country and then test the treatments in small towns and big cities around the nation where one in every 100 young adults and their families are handed the devastating diagnosis. This brain illness can cause hallucinations, delusions and life-disrupting changes in thought, mood and behavior.
Studies have shown that people with schizophrenia generally do not get appropriate treatments early enough in the course of the disease and this may lead to a more disabling form of the illness. Symptoms generally appear in late adolescence or early adulthood, and can disrupt the normal course of life and derail even the smartest minds.
Traditionally, patients have been given an inconsistent variety of treatments and studies show that most people never make it back to where they were before the symptoms hit. No one really knows how early, consistent, state-of-the-art treatments will affect the course of this illness, and this federal initiative is the first attempt to figure it out. The teams will be led by John Kane, MD, chairman of psychiatry at Zucker Hillside Hospital in Glen Oaks, NY, and Jeffrey Lieberman, MD, of Columbia University. âThis is novel because there has never been an attempt to study the impact of carefully integrated modern pharmacologic and psychosocial treatments in first-episode patients,â he said. âThis project will give us strategies that may change the course of illness for patients early in the disease process. We have some promising approaches that need to be combined and then tested on individuals in many different kinds of settings.
âWe have a sense of what treatments work, but these interventions havenât been tested in an integrated approach. This study is uniquely designed to answer the question of how best to treat people in the early stages of schizophrenia,â added Dr. Kane, internationally known for his work in the treatment of schizophrenia patients.
Once the interventions are selected and people trained to deliver them in a consistent fashion, 200 newly-diagnosed patients will be identified and enrolled in the study. The scientists will follow the patients over time to see whether their symptoms improve and if their social and vocational functioning get better with the selected interventions. The group will be tested against patients participating in the study and receiving standard psychiatric care in community clinics around the country.
âCan we do a better job helping patients with a more comprehensive treatment package? We definitely think so,â said Dr. Kane. âWe hope this study will not only help us to change the course and outcome of schizophrenia, but also to change the way that people think about this brain disease. We hope the study will demonstrate that schizophrenia can be effectively treated and managed so that individuals who experience its onset can have a high likelihood of recovering and doing many of the things that we all take for granted: going to school, working, having hobbies, friends and intimate relationships. Weâre very excited about this opportunity.â
âThis new initiative will help us determine whether intervention that is started early, incorporates diverse treatment and rehabilitation approaches, and is sustained over time, can make it possible for more people with schizophrenia to return successfully to work and school,â said NIMH Director Thomas R. Insel, M.D. âMoreover, the interventions being tested will be designed from the outset to be readily adopted in real-world health care settings and quickly put into practice.â
RAISE is a model example of how money from the Recovery Act can accelerate science related to public health problems and potentially benefit those citizens most in need.
For more information on the study: http://www.nimh.nih.gov/health/topics/schizophrenia/raise/index.shtml.
###
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.